Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Translational results from the Swedish randomised phase III, TEX trial show that breast cancer relapse characteristics display aggressive features, with an over-representation of ER-negative, HER2-positive and highly proliferative tumours.
The molecular subtype of breast cancer metastases significantly influences post-relapse survival, according to the study findings presented by Dr Nicholas Tobin of the Karolinska Institute, Stockholm, Sweden.
Click here to read the article in full.
Source: ESMO
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.